<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d110">
    <sentence id="DDI-DrugBank.d110.s0" text="The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.">
        <entity charOffset="28-47" id="DDI-DrugBank.d110.s0.e0" text="anesthetic solutions" type="group"/>
        <entity charOffset="60-70" id="DDI-DrugBank.d110.s0.e1" text="epinephrine" type="drug"/>
        <entity charOffset="75-88" id="DDI-DrugBank.d110.s0.e2" text="norepinephrine" type="drug"/>
        <entity charOffset="112-139" id="DDI-DrugBank.d110.s0.e3" text="monoamine oxidase inhibitors" type="group"/>
        <entity charOffset="142-166" id="DDI-DrugBank.d110.s0.e4" text="tricyclic antidepressants" type="group"/>
        <entity charOffset="171-184" id="DDI-DrugBank.d110.s0.e5" text="phenothiazines" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e0" e2="DDI-DrugBank.d110.s0.e1" id="DDI-DrugBank.d110.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e0" e2="DDI-DrugBank.d110.s0.e2" id="DDI-DrugBank.d110.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e0" e2="DDI-DrugBank.d110.s0.e3" id="DDI-DrugBank.d110.s0.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e0" e2="DDI-DrugBank.d110.s0.e4" id="DDI-DrugBank.d110.s0.p3" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e0" e2="DDI-DrugBank.d110.s0.e5" id="DDI-DrugBank.d110.s0.p4" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e1" e2="DDI-DrugBank.d110.s0.e2" id="DDI-DrugBank.d110.s0.p5"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e1" e2="DDI-DrugBank.d110.s0.e3" id="DDI-DrugBank.d110.s0.p6" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e1" e2="DDI-DrugBank.d110.s0.e4" id="DDI-DrugBank.d110.s0.p7" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e1" e2="DDI-DrugBank.d110.s0.e5" id="DDI-DrugBank.d110.s0.p8" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e2" e2="DDI-DrugBank.d110.s0.e3" id="DDI-DrugBank.d110.s0.p9" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e2" e2="DDI-DrugBank.d110.s0.e4" id="DDI-DrugBank.d110.s0.p10" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s0.e2" e2="DDI-DrugBank.d110.s0.e5" id="DDI-DrugBank.d110.s0.p11" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e3" e2="DDI-DrugBank.d110.s0.e4" id="DDI-DrugBank.d110.s0.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e3" e2="DDI-DrugBank.d110.s0.e5" id="DDI-DrugBank.d110.s0.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d110.s0.e4" e2="DDI-DrugBank.d110.s0.e5" id="DDI-DrugBank.d110.s0.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s1" text="Concurrent use of these agents should generally be avoided."/>
    <sentence id="DDI-DrugBank.d110.s2" text="In situations when concurrent therapy is necessary, careful patient monitoring is essential."/>
    <sentence id="DDI-DrugBank.d110.s3" text="Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents.">
        <entity charOffset="29-45" id="DDI-DrugBank.d110.s3.e0" text="vasopressor drugs" type="group"/>
        <entity charOffset="114-138" id="DDI-DrugBank.d110.s3.e1" text="ergot-type oxytocic drugs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s3.e0" e2="DDI-DrugBank.d110.s3.e1" id="DDI-DrugBank.d110.s3.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s4" text="The para-aminobenzoic acid metabolite of chloroprocaine inhibits the action of sulfonamides.">
        <entity charOffset="79-90" id="DDI-DrugBank.d110.s4.e0" text="sulfonamides" type="group"/>
    </sentence>
    <sentence id="DDI-DrugBank.d110.s5" text="Therefore, chloroprocaine should not be used in any condition in which a sulfonamide drug is being employed.">
        <entity charOffset="11-24" id="DDI-DrugBank.d110.s5.e0" text="chloroprocaine" type="drug"/>
        <entity charOffset="73-88" id="DDI-DrugBank.d110.s5.e1" text="sulfonamide drug" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d110.s5.e0" e2="DDI-DrugBank.d110.s5.e1" id="DDI-DrugBank.d110.s5.p0" type="advise"/>
    <negationtags>Therefore, chloroprocaine should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used in any condition in which a sulfonamide drug is being employed. &lt;/scope&gt;</negationtags></sentence>
</document>